Advances in understanding the contribution of Cav-1 in cancer progression and the clinical characteristics from stromal and cancer cells are likely to enhance the awareness and acknowledgement of the reciprocal signaling that supports and promotes oncogenesis, tumor differentiation, tumor stage, metastasis and survival. This evidence concerns the gene CAV1 and cancer.